AnVil has the domain expertise and industry experience to extract meaningful and valuable knowledge from data that is accessed through partnerships with life sciences companies and healthcare providers. Using the power of high-dimensional analysis and visualization, AnVil enables clients to see and interpret multiple data sets in integrated, information-rich views. This approach turns data into decision-quality information. This includes data on patient medical records, outcomes, and other healthcare information, as well as DNA microarrays, protein microarrays, cheminformatics, and high-throughput screening. For example, AnVil identifies valuable associations between demographic, therapeutic indications, pharmaceutical, and treatment outcome information.

Our Commercial Collaborations

AnVil collaborates with healthcare organizations, pharmacy benefit management (PBM) groups, clinics and other health-related entities to create partnerships and license intellectual property to pharmaceutical and biotechnology companies. This intellectual property is the knowledge, information and insights that AnVil extracts from its clients' large heterogeneous databases. These commercialization partnerships create new business opportunities for AnVil's partners. They also enable pharmaceutical and biotechnology companies to make better decisions, based on relevant healthcare information, and to improve the delivery of new and existing drugs.

Our Team

AnVil's integrated teams of chemists, life scientists, medical doctors, biostatisticians, mathematicians, informaticists, and software engineers not only mine data, but also generate and explore commercially relevant hypotheses, resulting in new, empowering knowledge. AnVil's methodology requires that informaticists and statisticians work closely with medical and life sciences experts in cross-functional teams. Such an approach provides a fruitful cross-fertilization of ideas and constructs. In addition, AnVil's business and marketing staff uses its extensive experience in technology transfer of intellectual property to market and license this knowledge to pharmaceutical and biotechnology clients.

Our Technology

AnVil combines data mining, statistical analysis and unique, high-dimensional visualization methods to reveal new and commercially valuable information in large, complex data sets from its healthcare, biotechnology and health insurance clients. AnVil has also developed proprietary algorithms and tools that support the robust analysis of these types of data, as well as specific capabilities in disease identification and outcome measure definitions.

Our Access to Data

AnVil's collaboration partners provide access to a wealth of relevant healthcare data from multiple and diverse sources including medical and pharmaceutical claims, organ transplant registries, and surgery center, in-patient hospital and in-patient rehabilitation records. AnVil's partners also provide genomics data derived from microarrays, blood samples and tissue samples. Database and software experts from AnVil work with clients to organize, clean, and normalize data that are often provided by these clients in disparate formats.

back to top